{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:28:31Z","timestamp":1777537711222,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008623","name":"Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA211015"],"award-info":[{"award-number":["P50-CA211015"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA163971"],"award-info":[{"award-number":["R01 CA163971"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA211015"],"award-info":[{"award-number":["P50-CA211015"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11060-020-03401-2","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T07:02:30Z","timestamp":1579849350000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma"],"prefix":"10.1007","volume":"147","author":[{"given":"Kunal S.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Kejriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel M.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samasuk","family":"Thammachantha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"Romiyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn K.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuri","family":"Wadehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5176-5615","authenticated-orcid":false,"given":"Isaac","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"3401_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314. https:\/\/doi.org\/10.1007\/s11060-010-0386-3","journal-title":"J Neurooncol"},{"key":"3401_CR2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa070972","volume":"357","author":"MW Vernooij","year":"2007","unstructured":"Vernooij MW, Ikram MA, Tanghe HL et al (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821\u20131828. https:\/\/doi.org\/10.1056\/NEJMoa070972","journal-title":"N Engl J Med"},{"key":"3401_CR3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/cncr.20088","volume":"100","author":"W Krampla","year":"2004","unstructured":"Krampla W, Newrkla S, Pfisterer W et al (2004) Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the Transdanube Ageing Study (VITA). Cancer 100:1208\u20131212. https:\/\/doi.org\/10.1002\/cncr.20088","journal-title":"Cancer"},{"key":"3401_CR4","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/FOC-07\/10\/E1","volume":"23","author":"J Rockhill","year":"2007","unstructured":"Rockhill J, Mrugala M, Chamberlain MC (2007) Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus 23:E1. https:\/\/doi.org\/10.3171\/FOC-07\/10\/E1","journal-title":"Neurosurg Focus"},{"key":"3401_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jnnp.21.2.89","volume":"21","author":"ER Bickerstaff","year":"1958","unstructured":"Bickerstaff ER, Small JM, Guest IA (1958) The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21:89\u201391. https:\/\/doi.org\/10.1136\/jnnp.21.2.89","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3401_CR6","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1158\/1055-9965.EPI-10-0447","volume":"19","author":"DS Michaud","year":"2010","unstructured":"Michaud DS, Gallo V, Schlehofer B et al (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562\u20132569. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-0447","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3401_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1755-8794-2-42","volume":"2","author":"Y Shen","year":"2009","unstructured":"Shen Y, Nunes F, Stemmer-Rachamimov A et al (2009) Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas. BMC Med Genomics 2:42. https:\/\/doi.org\/10.1186\/1755-8794-2-42","journal-title":"BMC Med Genomics"},{"key":"3401_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","volume":"20","author":"Y Lee","year":"2010","unstructured":"Lee Y, Liu J, Patel S et al (2010) Genomic landscape of meningiomas. Brain Pathol 20:751\u2013762. https:\/\/doi.org\/10.1111\/j.1750-3639.2009.00356.x","journal-title":"Brain Pathol"},{"key":"3401_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","volume":"159","author":"J Bostr\u00f6m","year":"2001","unstructured":"Bostr\u00f6m J, Meyer-Puttlitz B, Wolter M et al (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661\u2013669. https:\/\/doi.org\/10.1016\/S0002-9440(10)61737-3","journal-title":"Am J Pathol"},{"key":"3401_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/25867","volume":"395","author":"S Bates","year":"1998","unstructured":"Bates S, Phillips AC, Clark PA et al (1998) p14ARF links the tumour suppressors RB and p53. Nature 395:124\u2013125. https:\/\/doi.org\/10.1038\/25867","journal-title":"Nature"},{"key":"3401_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2119\/molmed.2010.00005","volume":"16","author":"I Laurendeau","year":"2010","unstructured":"Laurendeau I, Ferrer M, Garrido D et al (2010) Gene expression profiling of the hedgehog signaling pathway in human meningiomas. Mol Med 16:262\u2013270. https:\/\/doi.org\/10.2119\/molmed.2010.00005","journal-title":"Mol Med"},{"key":"3401_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1593\/neo.08356","volume":"10","author":"GS Baia","year":"2008","unstructured":"Baia GS, Stifani S, Kimura ET et al (2008) Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia 10:604\u2013612","journal-title":"Neoplasia"},{"key":"3401_CR13","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1158\/1078-0432.CCR-04-2550","volume":"11","author":"C Mawrin","year":"2005","unstructured":"Mawrin C, Sasse T, Kirches E et al (2005) Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 11:4074\u20134082. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2550","journal-title":"Clin Cancer Res"},{"key":"3401_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3171\/jns.2001.94.2.0293","volume":"94","author":"MD Johnson","year":"2001","unstructured":"Johnson MD, Woodard A, Kim P, Frexes-Steed M (2001) Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells. J Neurosurg 94:293\u2013300. https:\/\/doi.org\/10.3171\/jns.2001.94.2.0293","journal-title":"J Neurosurg"},{"key":"3401_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1014588214966","volume":"56","author":"MD Johnson","year":"2002","unstructured":"Johnson MD, Woodard A, Okediji EJ et al (2002) Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. J Neurooncol 56:133\u2013142","journal-title":"J Neurooncol"},{"key":"3401_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/00006123-200004000-00033","volume":"46","author":"K Lamszus","year":"2000","unstructured":"Lamszus K, Lengler U, Schmidt NO, et al (2000) Vascular endothelial growth factor, hepatocyte growth factor\/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 46:938\u2013947; discussion 947\u2013948. https:\/\/doi.org\/10.1097\/00006123-200004000-00033","journal-title":"Neurosurgery"},{"key":"3401_CR17","first-page":"1189","volume":"55","author":"K Samoto","year":"1995","unstructured":"Samoto K, Ikezaki K, Ono M et al (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189\u20131193","journal-title":"Cancer Res"},{"key":"3401_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3171\/jns.1997.86.1.0113","volume":"86","author":"DW Hsu","year":"1997","unstructured":"Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113\u2013120. https:\/\/doi.org\/10.3171\/jns.1997.86.1.0113","journal-title":"J Neurosurg"},{"key":"3401_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/02688699550041746","volume":"9","author":"A Verhagen","year":"1995","unstructured":"Verhagen A, Go KG, Visser GM et al (1995) The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas. Br J Neurosurg 9:47\u201350","journal-title":"Br J Neurosurg"},{"key":"3401_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2559.2003.01712.x","volume":"43","author":"AE Konstantinidou","year":"2003","unstructured":"Konstantinidou AE, Korkolopoulou P, Mahera H et al (2003) Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 43:280\u2013290","journal-title":"Histopathology"},{"key":"3401_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3171\/jns.2005.103.3.0508","volume":"103","author":"BT Ragel","year":"2005","unstructured":"Ragel BT, Jensen RL, Gillespie DL et al (2005) Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 103:508\u2013517. https:\/\/doi.org\/10.3171\/jns.2005.103.3.0508","journal-title":"J Neurosurg"},{"key":"3401_CR22","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/FOC-07\/10\/E7","volume":"23","author":"BT Ragel","year":"2007","unstructured":"Ragel BT, Jensen RL, Couldwell WT (2007) Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors. Neurosurg Focus 23:E7. https:\/\/doi.org\/10.3171\/FOC-07\/10\/E7","journal-title":"Neurosurg Focus"},{"key":"3401_CR23","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2013.10.FOCUS13360","volume":"35","author":"S He","year":"2013","unstructured":"He S, Pham MH, Pease M et al (2013) A review of epigenetic and gene expression alterations associated with intracranial meningiomas. Neurosurg Focus 35:E5. https:\/\/doi.org\/10.3171\/2013.10.FOCUS13360","journal-title":"Neurosurg Focus"},{"key":"3401_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/14737175.2016.1184087","volume":"16","author":"E Le Rhun","year":"2016","unstructured":"Le Rhun E, Taillibert S, Chamberlain MC (2016) Systemic therapy for recurrent meningioma. Expert Rev Neurother 16:889\u2013901. https:\/\/doi.org\/10.1080\/14737175.2016.1184087","journal-title":"Expert Rev Neurother"},{"key":"3401_CR25","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1158\/1535-7163.MCT-13-0199","volume":"13","author":"M Fu","year":"2014","unstructured":"Fu M, Maresh EL, Helguera GF et al (2014) Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Mol Cancer Ther 13:902\u2013915. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0199","journal-title":"Mol Cancer Ther"},{"key":"3401_CR26","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-10-0368","volume":"16","author":"M Fu","year":"2010","unstructured":"Fu M, Maresh EL, Soslow RA et al (2010) Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer. Clin Cancer Res 16:3954\u20133963. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0368","journal-title":"Clin Cancer Res"},{"key":"3401_CR27","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1002\/cncr.25259","volume":"116","author":"O Habeeb","year":"2010","unstructured":"Habeeb O, Goodglick L, Soslow RA et al (2010) Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development. Cancer 116:4718\u20134726. https:\/\/doi.org\/10.1002\/cncr.25259","journal-title":"Cancer"},{"key":"3401_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cncr.21957","volume":"107","author":"M Wadehra","year":"2006","unstructured":"Wadehra M, Natarajan S, Seligson DB et al (2006) Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer 107:90\u201398. https:\/\/doi.org\/10.1002\/cncr.21957","journal-title":"Cancer"},{"key":"3401_CR29","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1074\/jbc.M113.543728","volume":"289","author":"Y Qin","year":"2014","unstructured":"Qin Y, Fu M, Takahashi M et al (2014) Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma. J Biol Chem 289:13974\u201313985. https:\/\/doi.org\/10.1074\/jbc.M113.543728","journal-title":"J Biol Chem"},{"key":"3401_CR30","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1158\/0008-5472.CAN-04-0452","volume":"64","author":"WA Freije","year":"2004","unstructured":"Freije WA, Castro-Vargas FE, Fang Z et al (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503\u20136510. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0452","journal-title":"Cancer Res"},{"key":"3401_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-017-2507-8","volume":"134","author":"Y Qin","year":"2017","unstructured":"Qin Y, Takahashi M, Sheets K et al (2017) Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme. J Neurooncol 134:29\u201340. https:\/\/doi.org\/10.1007\/s11060-017-2507-8","journal-title":"J Neurooncol"},{"key":"3401_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1750-3639.2008.00191.x","volume":"19","author":"MD Tabernero","year":"2009","unstructured":"Tabernero MD, Maillo A, Gil-Bellosta CJ et al (2009) Gene expression profiles of meningiomas are associated with tumor cytogenetics and patient outcome. Brain Pathol 19:409\u2013420. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00191.x","journal-title":"Brain Pathol"},{"key":"3401_CR33","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3892\/or.2014.3526","volume":"32","author":"M Torres-Martin","year":"2014","unstructured":"Torres-Martin M, Lassaletta L, Isla A et al (2014) Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue. Oncol Rep 32:2327\u20132334. https:\/\/doi.org\/10.3892\/or.2014.3526","journal-title":"Oncol Rep"},{"key":"3401_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12885-017-3198-4","volume":"17","author":"AB Dalan","year":"2017","unstructured":"Dalan AB, Gulluoglu S, Tuysuz EC et al (2017) Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: a relationship between PTX3 and miR-29c. BMC Cancer 17:207. https:\/\/doi.org\/10.1186\/s12885-017-3198-4","journal-title":"BMC Cancer"},{"key":"3401_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12935-017-0441-7","volume":"17","author":"I Khan","year":"2017","unstructured":"Khan I, Baeesa S, Bangash M et al (2017) Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines. Cancer Cell Int 17:72. https:\/\/doi.org\/10.1186\/s12935-017-0441-7","journal-title":"Cancer Cell Int"},{"key":"3401_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/ijc.23942","volume":"124","author":"A Keller","year":"2009","unstructured":"Keller A, Ludwig N, Backes C et al (2009) Genome wide expression profiling identifies specific deregulated pathways in meningioma. Int J Cancer 124:346\u2013351. https:\/\/doi.org\/10.1002\/ijc.23942","journal-title":"Int J Cancer"},{"key":"3401_CR37","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/foc.2005.19.5.10","volume":"19","author":"BT Ragel","year":"2005","unstructured":"Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19:E9","journal-title":"Neurosurg Focus"},{"key":"3401_CR38","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2011.2.FOCUS1116","volume":"30","author":"W Choy","year":"2011","unstructured":"Choy W, Kim W, Nagasawa D et al (2011) The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus 30:E6. https:\/\/doi.org\/10.3171\/2011.2.FOCUS1116","journal-title":"Neurosurg Focus"},{"key":"3401_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-010-0381-8","volume":"99","author":"BT Ragel","year":"2010","unstructured":"Ragel BT, Jensen RL (2010) Aberrant signaling pathways in meningiomas. J Neurooncol 99:315\u2013324. https:\/\/doi.org\/10.1007\/s11060-010-0381-8","journal-title":"J Neurooncol"},{"key":"3401_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","volume":"465","author":"Y Wang","year":"2010","unstructured":"Wang Y, Nakayama M, Pitulescu ME et al (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465:483\u2013486. https:\/\/doi.org\/10.1038\/nature09002","journal-title":"Nature"},{"key":"3401_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/sni.sni_264_17","volume":"9","author":"AJ Franke","year":"2018","unstructured":"Franke AJ, Skelton WP, Woody LE et al (2018) Role of bevacizumab for treatment-refractory meningiomas: a systematic analysis and literature review. Surg Neurol Int 9:133. https:\/\/doi.org\/10.4103\/sni.sni_264_17","journal-title":"Surg Neurol Int"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03401-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-020-03401-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03401-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:51:11Z","timestamp":1611363071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-020-03401-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3401"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03401-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M.W and L.K.G. are inventors on the University of California patents related to anti-EMP2 monoclonal antibodies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}